Flebbe, H.; Spitzner, M.; Marquet, P.E.; Gaedcke, J.; Ghadimi, B.M.; Rieken, S.; Schneider, G.; Koenig, A.O.; Grade, M.
Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy. Cancers 2022, 14, 1301.
https://doi.org/10.3390/cancers14051301
AMA Style
Flebbe H, Spitzner M, Marquet PE, Gaedcke J, Ghadimi BM, Rieken S, Schneider G, Koenig AO, Grade M.
Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy. Cancers. 2022; 14(5):1301.
https://doi.org/10.3390/cancers14051301
Chicago/Turabian Style
Flebbe, Hannah, Melanie Spitzner, Philipp Enno Marquet, Jochen Gaedcke, B. Michael Ghadimi, Stefan Rieken, Günter Schneider, Alexander O. Koenig, and Marian Grade.
2022. "Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy" Cancers 14, no. 5: 1301.
https://doi.org/10.3390/cancers14051301
APA Style
Flebbe, H., Spitzner, M., Marquet, P. E., Gaedcke, J., Ghadimi, B. M., Rieken, S., Schneider, G., Koenig, A. O., & Grade, M.
(2022). Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy. Cancers, 14(5), 1301.
https://doi.org/10.3390/cancers14051301